Reported Do Pass (H)
Summary
The bill lets patients with terminal, life‑threatening, or severely debilitating conditions obtain drugs, biologics, or devices that have passed Phase I trials but are not FDA‑approved. It sets eligibility criteria, lets manufacturers provide the products for free or at cost, and shields doctors and providers from license or legal actions for recommending or using them. Insurers and the state prison system are not required to cover the costs.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 2922 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 2922 freeOr ask your AI assistant about HB 2922 directly:
Add to Claude, ChatGPT or Cursor